/주식/INSM
INSM

INSM

USD

Insmed Incorporated Common Stock

$182.770-2.510 (-1.355%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$185.280

고가

$187.880

저가

$182.580

거래량

1.57M

기업 기본 정보

시가총액

39.0B

산업

생명공학

국가

United States

거래 통계

평균 거래량

2.46M

거래소

NMS

통화

USD

52주 범위

저가 $60.4현재가 $182.770고가 $197.08

관련 뉴스

Analyst Upgrades

Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $217

Wells Fargo analyst Tiago Fauth maintains Insmed with a Overweight and raises the price target from $171 to $217.

더 보기
Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $217
Analyst Upgrades

Goldman Sachs Maintains Buy on Insmed, Raises Price Target to $225

Goldman Sachs analyst Andrea Tan maintains Insmed with a Buy and raises the price target from $196 to $225.

더 보기
Goldman Sachs Maintains Buy on Insmed, Raises Price Target to $225
Analyst Upgrades

UBS Maintains Buy on Insmed, Raises Price Target to $223

UBS analyst Trung Huynh maintains Insmed with a Buy and raises the price target from $194 to $223.

더 보기
UBS Maintains Buy on Insmed, Raises Price Target to $223
Analyst Upgrades

RBC Capital Maintains Outperform on Insmed, Raises Price Target to $215

RBC Capital analyst Leonid Timashev maintains Insmed with a Outperform and raises the price target from $139 to $215.

더 보기
RBC Capital Maintains Outperform on Insmed, Raises Price Target to $215
Analyst Upgrades

B of A Securities Maintains Buy on Insmed, Raises Price Target to $187

B of A Securities analyst Jason Zemansky maintains Insmed with a Buy and raises the price target from $142 to $187.

더 보기
B of A Securities Maintains Buy on Insmed, Raises Price Target to $187
Analyst Upgrades

UBS Maintains Buy on Insmed, Raises Price Target to $194

UBS analyst Trung Huynh maintains Insmed with a Buy and raises the price target from $140 to $194.